|
 |
|
R&D and BUSINESS DEVELOPMENT STRATEGY
|
Methods and Tools
|
New Product Planning
- Providing an understanding of the emerging clinical and market
needs around products in clinical development
- Conducting in-depth analyses of targeted indications, relevant
patient populations, and prescriber patterns
- Devising indication strategies for early stage clinical compounds
- Developing target product profiles required to compete within
current and future standards of care
- Determining optimal positioning and pricing strategies
- Forecasting market potential under various market scenarios
R&D Portfolio Valuation
- Conducting R&D portfolio assessments using scientific and business
evaluations
- Assessing critical licensing candidates
- Profiling potential indications for pipeline compounds
- Forecasting market potential for product portfolios
- Facilitating senior management in "Go/No Go" decision-making
Business Opportunity Assessment
- Developing futuristic and alternative healthcare and pharmaceutical
scenarios as a framework for business planning
- Identifying and evaluating potential business opportunities
within key growth areas to maximize revenue and earnings
- Evaluating potential partnerships along the business opportunity
value chain
- Creating business cases for executive management to facilitate
resource allocation decisions
- Streamlining the business assessment processes within an organization
Technology Assessment
- Evaluating novel technologies and products
- Determining market feasibility of innovative concepts and technologies
- Performing financial valuations of new technology platforms
\
- Assessing the impact of new technologies on a firm's business
- Incorporating new technologies to re-engineer R&D processes
|
|